Forcythia SAS
↗Le Pecq, France
Forcythia SAS is a specialized pharmaceutical and biotechnology engineering consultancy based in France. The firm provides high-level technical expertise in aseptic manufacturing processes, focusing on the integration of fully automated robotic filling systems and advanced isolator technologies.
The company serves as a strategic partner for life sciences organizations, assisting in the definition of complex User Requirement Specifications (URS) and the implementation of robust quality management systems. Forcythia is particularly active in helping manufacturers navigate the regulatory requirements of EU GMP Annex 1 and ICHQ10, ensuring that sterile production environments meet the highest global standards.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Engineering & Consulting
SIZE & FINANCIALS
Employees:1-50
Revenue:<$1M (Estimated)
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Bootstrapped
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Aseptic processing, Fill-finish, Robotics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:A3P Association (Active industry collaboration and training), Tofflon (Historical technical association)
COMPETITION
Position:Niche Player
Competitors:Aktehom, NNE, Pharmaplan, Technip Energies (Life Sciences division)
LEADERSHIP
Key Executives:
Mats Mickos - Director & Founder
Scientific Founders:Mats Mickos
LINKS
Website:forcythia.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Forcythia SAS. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.